Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Singer

Showing results (221-230 of 253) with videos related to

Pageof 26
Sort By:
JAMA Oncology|July 22, 2021
Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 PandemicAdrien N Bernstein, Ruchika Talwar, Elizabeth Handorf, et al.
International Journal of Molecular Sciences|January 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate CancerJack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
Cancers|May 27, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional AnalysisEvan R Adler, Anwaruddin Mohammad, Pankaj Kumar, et al.
Prostate International|September 6, 2019
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancerBertram E Yuh, Young Suk Kwon, Brian M Shinder, et al.
Cancer Gene Therapy|June 22, 2019
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinomaDaniella E Portal, Robert E Weiss, Malgorzata Wojtowicz, et al.
Urologic Oncology|June 25, 2023
Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborativeThenappan Chandrasekar, Andrew Denisenko, Vasil Mico, et al.
The New England Journal of Medicine|June 18, 2025
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney CancerRamaprasad Srinivasan, Sandeep Gurram, Eric A Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2022
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO GuidelineW Kimryn Rathmell, R Bryan Rumble, Peter J Van Veldhuizen, et al.
Cancer|April 25, 2020
Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancerArnav Srivastava, Zorimar Rivera-Núñez, Sinae Kim, et al.
Pageof 26

Showing results (221-230 of 253) with videos related to

Sort By:
Pageof 26
JAMA Oncology|July 22, 2021
Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 PandemicAdrien N Bernstein, Ruchika Talwar, Elizabeth Handorf, et al.
International Journal of Molecular Sciences|January 25, 2025
Clinical and Genomic Features of Androgen Indifferent Prostate CancerJack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
Cancers|May 27, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional AnalysisEvan R Adler, Anwaruddin Mohammad, Pankaj Kumar, et al.
Prostate International|September 6, 2019
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancerBertram E Yuh, Young Suk Kwon, Brian M Shinder, et al.
Cancer Gene Therapy|June 22, 2019
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinomaDaniella E Portal, Robert E Weiss, Malgorzata Wojtowicz, et al.
Urologic Oncology|June 25, 2023
Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborativeThenappan Chandrasekar, Andrew Denisenko, Vasil Mico, et al.
The New England Journal of Medicine|June 18, 2025
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney CancerRamaprasad Srinivasan, Sandeep Gurram, Eric A Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2022
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO GuidelineW Kimryn Rathmell, R Bryan Rumble, Peter J Van Veldhuizen, et al.
Cancer|April 25, 2020
Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancerArnav Srivastava, Zorimar Rivera-Núñez, Sinae Kim, et al.
Pageof 26